首页> 外文期刊>Clinical and experimental hypertension: CEH >TRPV4 activation in rat carotid artery in DOCA hypertension involves eNOS and endothelium-derived contractile factor (EDCF)
【24h】

TRPV4 activation in rat carotid artery in DOCA hypertension involves eNOS and endothelium-derived contractile factor (EDCF)

机译:DOCA高血压大鼠颈动脉的TRPV4活化涉及ENOS和内皮衍生的收缩因子(EDCF)

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: Role of TRPV4 channel in regulation of endothelial function in the carotid artery in deoxycorticos-terone acetate (DOCA) model of hypertension in rat was studied. Methods: 8-10 weeks old albino Wistar rats divided into three groups namely Control, UNX and hypertensive animals. Vascular smooth muscle response was studied in isolated carotid artery of rat with acetylcholine, sodium nitroprusside, GSK1016790A (GSK) in presence and absence of L-NAME and indomethacin. Results: At the end of the 6th week, the mean systolic blood pressure was increased in DOCA-treated hypertensive rats (166 ±8 mm Hg) compared to Control and UNX (125 ±5 mm Hg). ACh (10-9 to 10-5 M) produced almost 100% relaxation in Control (Emax = 97.48 ± 1.06 %) and UNX animals (Emax = 93.16 ± 2.33 %) which was attenuated in DOCA-treated hypertensive animals (Emax = 70.85 ± 1.65 %). No significant changes seen in SNP (10-12 to 10-5 M) induced relaxation. GSK1016790A (10-12 to 10-7 M)-mediated relaxation was significantly attenuated in DOCA-treated hypertensive animals (Emax = 25.58 ± 13.60%) compared to the control (Emax = 80.59 ± 6.86%) and UNX (Emax = 87.32 ± 2.01%) animals. L-NAME (10-4 M) potently blocked GSK-induced relaxation, and a contractile response to GSK was observed in presence of L-NAME in all the three groups of animals which was sensitive to indomethacin (10-5 M). Conclusion: TRPV4 may regulate the vascular tone of rat carotid artery through an attenuated NO pathway and stimulation of the release of contractile prostanoids in the DOCA hypertensive rats.
机译:目的:研究了TRPV4通道在大鼠脱氧动脉中颈动脉中内皮功能调节的作用。方法:8-10周的白化白血病大鼠分为三组,即控制,UNX和高血压动物。研究了乙酰胆碱,硝普钠,GSK1016790A(GSK)在L-Name和Indomethacin的情况下分离的颈动脉中研究了血管平滑肌反应。结果:在第6周结束时,与对照和UNX(125±5mm Hg)相比,Doca治疗的高血压大鼠(166±8mm)增加了平均收缩压。 ACH(10-9至10-5米)在对照(EMAX = 97.48±1.06%)和UNX = 93.16±2.33%中产生了几乎100%的弛豫,该动物(Emax = 93.16±2.33%)在Doca治疗的高血压动物中衰减(Emax = 70.85 ±1.65%)。 SNP中没有显着改变(10-12至10-5米)诱导放松。与对照(Emax = 80.59±6.86%)和UNX相比,GSK1016790A(10-12至10-7米)介导的松弛在Doca治疗的高血压动物(Emax = 25.58±13.60%)中显着减弱(Emax = 25.58±13.60%)(Emax = 87.32± 2.01%)动物。 L-NAME(10-4米)有效地阻断了GSK诱导的放松,并且在对吲哚美辛(10-5米)敏感的所有三组动物中,在L-NAME存在下观察到GSK的收缩响应。结论:TRPV4可以通过减毒的无途径调节大鼠颈动脉的血管间距,并刺激DOCA高血压大鼠收缩前列腺释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号